- ASSISTANT PROFESSOR Medicine, Hematology and Medical Oncology
- ASSISTANT PROFESSOR Oncological Sciences
Practice consists of diversified population with variety of tumors, including breast, GI, GYN, Lung, Prostate, Germ Cell, Lymphomas, Sarcomas.
Cancer of unknown primary site, participation in CALB protocols for variety of cancers.
Benisovich V. Cancer of Unknown Origin. In: Rosenthal J, editor. Neoplastic Diseases, Pathology, Diagnosis, Therapy. Chicago, Precept Press; 1991. pp798-809.
Benisovich VI, Silverman L, Stone N, Cohen E. Cisplatin-based chemotherapy in renal transplant recipients. A case report and a review of the literature. Cancer 1996; 77(1): 160-163.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Benisovich did not report having any of the following types of financial relationships with industry during 2014 and/or 2015: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
Elmhurst Hospital Room H2-04
Elmhurst, NY 11373